Multitarget Therapy for Induction Treatment of Lupus Nephritis

被引：10
|
作者：
Liu, Zhihong
Zhang, H.
Liu, Zhangsuo
Xing, C.
Fu, P.
Ni, Z.
Chen, J.
Lin, H.
Liu, F.
He, Yongcheng
He, Yani
Miao, L.
Chen, N.
Li, Y.
Gu, Y.
Shi, W.
Hu, W.
Liu, Zhengzhao
Bao, H.
Zeng, C.
Zhou, M.
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 2015年 / 162卷 / 01期
关键词：
D O I：
10.7326/P15-9000
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：I24 / I24
页数：1
相关论文
共 50 条
  • [21] MULTITARGET THERAPY IN PATIENTS WITH LUPUS NEPHRITIS: A TWO YEAR FOLLOW UP REPORT
    Casillas-Ramos, Gisela E.
    Andrade-Ortega, Lilia
    Irazoque-Palazuelos, Fedra
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S16 - S16
  • [22] TREATMENT OF LUPUS NEPHRITIS WITH COMBINED THERAPY
    KIMBERLY, RP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (10): : 564 - 564
  • [23] Effect of Induction Therapy on Glomerular Morphometry in Lupus Nephritis
    Pichaiwong, Warangkana
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 488 - 488
  • [24] Are steroids required for induction therapy and relapses in lupus nephritis?
    Abud-Mendoza, Carlos
    Gonzalez-Amaro, Roberto
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (12) : E29 - E29
  • [25] Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis
    Choi, C-B
    Won, S.
    Bae, S-C
    [J]. LUPUS, 2018, 27 (06) : 1007 - 1011
  • [26] A Pilot Study of Consensus Treatment Plans for Induction Therapy in Childhood Proliferative Lupus Nephritis
    Cooper, Jennifer C.
    Eberhard, B. Anne
    Punaro, Marilynn
    Ardoin, Stacy P.
    Brunner, Hermine I.
    Hsu, Joyce
    Wagner-Weiner, Linda
    Rouster-Stevens, Kelly
    Schanberg, Laura E.
    Klein-Gitelman, Marisa
    von Scheven, Emily
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [27] Lupus Nephritis: Induction Therapy in Severe Lupus Nephritis-Should MMF Be Considered the Drug of Choice?
    Rovin, Brad H.
    Parikh, Samir V.
    Hebert, Lee A.
    Chan, Tak Mao
    Mok, Chi Chiu
    Ginzler, Ellen M.
    Hooi, Lai Seong
    Brunetta, Paul
    Maciuca, Romeo
    Solomons, Neil
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (01): : 147 - 153
  • [28] Mycophenolate mofetil for the induction and maintenance treatment of lupus nephritis
    Gonzalez-Rivera, Tania C.
    McCune, Joseph
    [J]. IMMUNOTHERAPY, 2011, 3 (12) : 1431 - 1440
  • [29] Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus
    Mina, Rina
    von Scheven, Emily
    Ardoin, Stacy P.
    Eberhard, B. Anne
    Punaro, Marilynn
    Ilowite, Norman
    Hsu, Joyce
    Klein-Gitelman, Marisa
    Moorthy, L. Nandini
    Muscal, Eyal
    Radhakrishna, Suhas M.
    Wagner-Weiner, Linda
    Adams, Matthew
    Blier, Peter
    Buckley, Lenore
    Chalom, Elizabeth
    Chedeville, Gaelle
    Eichenfield, Andrew
    Fish, Natalya
    Henrickson, Michael
    Hersh, Aimee O.
    Hollister, Roger
    Jones, Olcay
    Jung, Lawrence
    Levy, Deborah
    Lopez-Benitez, Jorge
    McCurdy, Deborah
    Miettunen, Paivi M.
    Quintero-Del Rio, Ana I.
    Rothman, Deborah
    Rullo, Ornella
    Ruth, Natasha
    Schanberg, Laura E.
    Silverman, Earl
    Singer, Nora G.
    Soep, Jennifer
    Syed, Reema
    Vogler, Larry B.
    Yalcindag, Ali
    Yildirim-Toruner, Cagri
    Wallace, Carol A.
    Brunner, Hermine I.
    [J]. ARTHRITIS CARE & RESEARCH, 2012, 64 (03) : 375 - 383
  • [30] Induction therapy with rituximab for lupus nephritis due to prolidase deficiency
    Sato, Satoshi
    Ohnishi, Takuma
    Uejima, Yoji
    Furuichi, Mihoko
    Fujinaga, Shuichiro
    Imai, Kohsuke
    Nakamura, Kimitoshi
    Kawano, Yutaka
    Suganuma, Eisuke
    [J]. RHEUMATOLOGY, 2020, 59 (10) : E57 - E59
12345